The use of transdermal optical coherence tomography to image the superficial temporal arteries – (Eye 31, 157 (January 2017))
The use of transdermal optical coherence tomography to image the superficial temporal arteries Eye 31, 157 (January 2017). doi:10.1038/eye.2016.206 Authors: S P Mollan, P A Keane & A K Denniston
Can photoreceptor loss also account for changes in pupil size following panretinal photocoagulation? – (Eye 31, 161 (January 2017))
Can photoreceptor loss also account for changes in pupil size following panretinal photocoagulation? Eye 31, 161 (January 2017). doi:10.1038/eye.2016.210 Authors: R P Najjar & D Milea
Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents – (Eye 31, 1 (January 2017))
Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents Eye 31, 1 (January 2017). doi:10.1038/eye.2016.208 Authors: M Gemenetzi, A J Lotery & P J Patel
Structural and molecular changes in the aging choroid: implications for age-related macular degeneration – (Eye 31, 10 (January 2017))
Structural and molecular changes in the aging choroid: implications for age-related macular degeneration Eye 31, 10 (January 2017). doi:10.1038/eye.2016.216 Authors: K R Chirco, E H Sohn, E M Stone, B A Tucker & R F Mullins
A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration – (Eye 31, 26 (January 2017))
A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration Eye 31, 26 (January 2017). doi:10.1038/eye.2016.227 Authors: U Schmidt-Erfurth, S Klimscha, S M Waldstein & H Bogunović